2-Chloroadenine

We are 2-Chloroadenine CAS:1839-18-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Chloroadenine
CAS.NO:1839-18-5
Synonyms:6-Amino-2-chloropurine
2-CHLORO-9H-PURIN-6-AMINE
2-CHLORO-6-AMINOPURINE
6-amino-2-chloro-9H-purine
CHLOROADENINE;
Molecular Formula:C5H4ClN5
Molecular Weight:169.57200
 
Physical and Chemical Properties:
Density:1.77;
Index of Refraction:1.956;
 
Specification:
Appearance:Light yellow to off-white powder
Assay(HPLC):≥98.0%
Loss on drying:≤1.0%
Residue on ignition:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Clofarabine and Cladribine intermediate.

2-Chloroadenine


Related News: Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.Hexamethyldisilane Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.decyl prop-2-enoate CAS:2156-96-9 Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.143254-82-4 Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.

Related Products
Product Name
(R,E)-ethyl 5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate View Details
2-Amino-4-bromobenzoic acid View Details
4-octylbenzoic acid View Details
2-(5-bromo-2-fluorobenzyl)-1-benzothiophene manufacturer Pentapeptide-31 manufacturer 3-Fluoro-4-morpholinoaniline manufacturer 1-bromodibenzo[b,d]furan manufacturer 1H-1,2,4-triazole manufacturer